Gene Therapy Test at University of Pennsylvania Halted After Man Dies

At a glance:

Article abstract: After the death of an eighteen-year-old test subject, the U.S. government decided to monitor human gene therapy experimentation more closely.

Human Gene Therapy

On January 21, 2000, the Food and Drug Administration (FDA) halted all human gene therapy at the University of Pennsylvania because of the death of one of the test subjects in the Human Gene Therapy Institute’s experimental program. Jesse Gelsinger, an eighteen-year-old Arizona man, had a toxic reaction within hours of receiving the gene therapy treatment and died within a few...

[The entire page is 843 words long]

Join eNotes

The above is a free excerpt. Get total access to this content with the: